首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

胰島素輸注裝置市場規模、佔有率及成長分析（依產品類型、糖尿病類型、最終用戶及地區分類）－2025-2032年產業預測

市場調查報告書

商品編碼

1865314

胰島素輸注裝置市場規模、佔有率及成長分析（依產品類型、糖尿病類型、最終用戶及地區分類）－2025-2032年產業預測

Insulin Delivery Devices Market Size, Share, and Growth Analysis, By Product Type (Insulin Pens, Insulin Pumps (Tethered)), By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes), By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月07日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2023 年，全球胰島素輸送設備市場規模將達到 167 億美元，到 2024 年將達到 180.2 億美元，到 2032 年將達到 331.1 億美元，預測期（2025-2032 年）的複合年成長率為 7.9%。

由於糖尿病盛行率不斷上升，全球胰島素輸注設備市場正經歷顯著成長。這種需求的激增推動了先進、便利的糖尿病管理系統的發展。數位技術，特別是持續血糖監測（CGM）系統的應用，透過基於持續血糖值監測結果即時調整胰島素劑量，提高了胰島素輸注的效率。此外，穿戴式和貼片式胰島素幫浦也越來越受歡迎，它們能夠以隱藏便捷的方式持續輸注胰島素。該領域的創新，例如尖端貼片式胰島素幫浦系統的新應用，凸顯了技術的不斷進步，進一步推動了市場擴張，並改善了患者的糖尿病管理體驗。

全球胰島素輸注設備市場促進因素

全球胰島素輸注設備市場的主要驅動力在於一個可互通生態系統的興起，該生態系統將胰島素輸注系統與持續血糖監測儀 (CGM)、智慧型手機應用程式、智慧胰島素筆和連網胰島素幫浦整合在一起。這種整合提高了給藥精度，增強了患者對治療方案的依從性，並方便醫護人員進行遠端監測，從而降低了低血糖事件的發生頻率，減少了患者就診次數。此外，遠距遠端醫療和數位糖尿病管理計畫的報銷機會不斷擴大，也推動了連網設備在居家照護和門診環境中的應用，增強了臨床醫生的信心，並讓患者更加安心。

全球胰島素輸送裝置市場阻礙因素

全球胰島素輸注設備市場面臨許多挑戰，其中設備及其耗材（尤其是自動胰島素幫浦和整合系統）的高成本限制了價格敏感地區的普及。不同地區的健保報銷政策差異進一步阻礙了這些技術的推廣，導致在醫保覆蓋範圍有限的情況下，推廣速度更為緩慢。支付方不願核准諸如貼片式胰島素幫浦和封閉回路型系統等新興技術，也構成了市場准入的障礙。為了擴大健保覆蓋範圍並降低成本，製造商必須證明其產品的價值和可行性，才能獲得醫保支付方的必要支援。

全球胰島素注射裝置市場趨勢

緊湊型無導管貼片式胰島素幫浦的普及是全球胰島素輸注設備市場的一大趨勢，反映出使用者對簡單易用解決方案的偏好。這些創新系統簡化了胰島素給藥流程，並提高了糖尿病患者的生活品質。隨著技術進步，智慧型手機控制和自動化演算法的應用日益普及，這些設備也變得越來越受歡迎，尤其受到那些對傳統胰島素幫浦猶豫不決的患者的青睞。這項變化不僅有助於改善糖尿病管理，也標誌著整個市場正朝著以患者為中心、更人性化的胰島素輸注方式轉變。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2024 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2024 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2022-2024年營收年比比較

主要企業簡介

Medtronic plc
Insulet Corporation
Novo Nordisk A/S
Sanofi
Eli Lilly and Company
Ypsomed AG
B. Braun SE
Owen Mumford Ltd.
BD（Becton, Dickinson and Company）
Tandem Diabetes Care, Inc.
Roche Holding AG（Diabetes Care Division）
Abbott Laboratories（Diabetes Care）
Johnson & Johnson（Diabetes Solutions）
Dexcom, Inc.（Integrated pump solutions）
Ascensia Diabetes Care Holdings AG
SOOIL Development Co., Ltd.
Nippon Boehringer Ingelheim Co., Ltd.
Terumo Corporation
AgaMatrix
Omron Healthcare Co., Ltd.

結論與建議

簡介目錄

Product Code: SQMIG35B2261

Global Insulin Delivery Devices Market size was valued at USD 16.7 billion in 2023 and is poised to grow from USD 18.02 billion in 2024 to USD 33.11 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global market for insulin delivery devices is experiencing significant growth driven by the rising prevalence of diabetes. This surge in demand is prompting the development of advanced, user-friendly diabetes management systems. The integration of digital technologies, particularly Continuous Glucose Monitoring (CGM) systems, is enhancing insulin delivery by enabling real-time adjustments of insulin doses based on continuous blood glucose monitoring. Additionally, wearable and patch insulin pumps are gaining traction, offering discreet and convenient methods for administering continuous insulin infusion. Innovations in this sector, such as new applications for cutting-edge patch insulin pump systems, highlight the ongoing advancements in technology, further propelling market expansion and improving patient experiences in diabetes management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Delivery Devices Market Segments Analysis

Global Insulin Delivery Devices Market is segmented by Product Type, Diabetes Type, End-User and region. Based on Product Type, the market is segmented into Insulin Pens, Insulin Pumps (Tethered), Insulin Pumps (Tubeless / Patch), Insulin Syringes & Needles and Smart Insulin Delivery Devices. Based on Diabetes Type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other Special Populations. Based on End-User, the market is segmented into Home Care / Self-administration, Hospitals & Clinics and Specialized Diabetes Care Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Delivery Devices Market

The global market for insulin delivery devices is being significantly propelled by the emergence of interoperable ecosystems that integrate insulin delivery systems with continuous glucose monitors (CGMs), smartphone applications, smart pens, and connected pumps. This integration enhances dosing precision, bolsters patient adherence to treatment plans, and facilitates remote monitoring by healthcare providers, thereby reducing the frequency of hypoglycemic events and lowering hospital visits. Additionally, growing reimbursement opportunities for telehealth and digital diabetes management programs are paving the way for more connected devices within home care and outpatient settings, fostering greater confidence among clinicians and promoting a sense of comfort for patients.

Restraints in the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market faces significant challenges due to the high costs associated with devices and their consumables, especially with automated pumps and integrated systems, which limits accessibility for price-sensitive regions. Variations in reimbursement policies across different regions further impede the adoption of these technologies, resulting in delays when coverage is restricted. This reluctance from payers to endorse emerging technologies, such as patch pumps and closed-loop systems, poses barriers to market entry. For broader coverage and affordability, manufacturers must demonstrate the value and feasibility of their offerings to gain the necessary support from healthcare payers.

Market Trends of the Global Insulin Delivery Devices Market

The global insulin delivery devices market is witnessing a significant trend towards the adoption of smaller, tubeless patch pumps, reflecting a user preference for streamlined and convenient solutions. These innovative systems simplify insulin administration, thereby enhancing the quality of life for diabetic patients. As advancements in technology lead to the incorporation of smartphone controls and automated algorithms, the appeal of these devices is growing, particularly among individuals hesitant to use traditional pumps. This shift not only supports better management of diabetes but also indicates a broader movement within the market towards more patient-centric, user-friendly insulin delivery methods.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape

Global Insulin Delivery Devices Market Size by Product Type & CAGR (2025-2032)

Market Overview
Insulin Pens
Insulin Pumps (Tethered)
Insulin Pumps (Tubeless / Patch)
Insulin Syringes & Needles
Smart Insulin Delivery Devices

Global Insulin Delivery Devices Market Size by Diabetes Type & CAGR (2025-2032)

Market Overview
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Other Special Populations

Global Insulin Delivery Devices Market Size by End-User & CAGR (2025-2032)

Market Overview
Home Care / Self-administration
Hospitals & Clinics
Specialized Diabetes Care Centres

Global Insulin Delivery Devices Market Size & CAGR (2025-2032)

North America (Product Type, Diabetes Type, End-User)
- US
- Canada
Europe (Product Type, Diabetes Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Diabetes Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Diabetes Type, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Diabetes Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Diabetes Care Division)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (Diabetes Care)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (Diabetes Solutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (Integrated pump solutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SOOIL Development Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nippon Boehringer Ingelheim Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments